Heidelberg Pharma AG (HPHA) — Capital Reinvestment Ratio

Latest as of May 2022: 0.00x

Heidelberg Pharma AG (HPHA) has a Capital Reinvestment Ratio of 0.00x as of May 2022, meaning it reinvests 0% of its operating cash flow (€13.59 Million) in capital expenditures (€50.81K). Check how tangible is Heidelberg Pharma AG's equity to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

€13.59 Million

EUR

Capital Expenditures

€50.81K

EUR

Data as of

May 2022

Most recent filing

Annual Capital Reinvestment Ratio for Heidelberg Pharma AG (None–None)

Year-by-year Capital Reinvestment Ratio for Heidelberg Pharma AG from None to None. See Heidelberg Pharma AG (HPHA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow